Clinical Trial Update: Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy, safety, and immunogenicity of the Rotavirus RV3 vaccine (Bio Farma) in neonates for rotavirus gastroenteritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Rotavirus RV3 Vaccine (Bio Farma) (Rotavirus vaccine)

Snippet

Sponsor: PT Bio Farma | Conditions: Rotavirus Gastroenteritis | Phase 3 | Status: COMPLETED